Exciting developments in allogeneic cell therapies! 🧬🔬 GlobalData highlights the potential of off-the-shelf treatments for blood cancers and B-cell malignancies, with positive results and promising market forecasts. Read more in their latest report. eu1.hubs.ly/H04B8rB0

🔬🦠 Oncolytic viruses in cancer treatment: A promising approach, yet facing challenges. While other immunotherapies advance, oncolytic viruses remain in early stages of development. Read more: eu1.hubs.ly/H04F5Cx0 #Immunotherapy #OncolyticViruses

🚨 Medtronic's recall of nearly 350,000 implantable cardioverter defibrillators (ICDs) has shaken its position in the market, opening opportunities for competitors like Abbott and Boston Scientific to gain ground. 🏥 eu1.hubs.ly/H04Hc310 #ICDRecall #HealthTech #MedicalDevices

Want to stay ahead of the competition? Subscribe to Decoded, our daily round-up of curated news & gold-standard intelligence for your industry. Subscribe today to give your business an edge: eu1.hubs.ly/H04KMpj0

Sanders's proposed bill may face legal opposition from big pharma, impacting US drug prices and global standardization efforts. Find out more: eu1.hubs.ly/H04Lvv_0

Pharmaceutical industry's investment in robotics is revolutionizing cell and gene therapy manufacturing, promising improved quality control and wider patient access to life-changing treatments. 🚀💊 eu1.hubs.ly/H04Nfkp0 #PharmaInnovation #CellTherapy #GeneTherapy #Robotics

Generative AI holds promise in revolutionizing healthcare by addressing administrative inefficiencies and improving diagnostic processes, but concerns about accuracy and misinformation must be carefully addressed. Learn more: eu1.hubs.ly/H04PlK20 #HealthcareAI #GenerativeAI

🏥🏥 Top US hyperscalers delve into generative AI for healthcare's administrative challenges and diagnostics improvement, showcasing promising applications; however, scrutiny over accuracy and privacy raises caution. eu1.hubs.ly/H04RHbS0 #GenerativeAI #HealthcareInnovation

Discover the impact of AI in clinical practice with GlobalData's report. Explore AI's current use, physicians' opinions, and potential improvements in healthcare. Stay ahead in the industry and gain a competitive edge: eu1.hubs.ly/H04SHhd0 #AIinClinicalPractice

Harness the power of the 'AI in Healthcare' report's predictive analysis, identifying industry disruptors, key players, and strategic opportunities, to navigate the dynamic landscape with confidence: eu1.hubs.ly/H04TK_f0

🚀 ChatGPT's launch sparked global interest and funding frenzy, propelling generative AI to the forefront. But as hype outpaces development, concerns arise over misinformation, understanding limitations, and its evolution into a substantial technology. 💡 eu1.hubs.ly/H04V7DZ0

Generative AI is set to explode, reaching a $33 billion market by 2027 with an 80% CAGR, transforming industries like IT, manufacturing, and healthcare. US leads, Brazil & India grow fast, propelling creative content and innovation. Read more: eu1.hubs.ly/H04W2G00

📢 Clinigen divests global rights for four cancer therapies, including Cardioxane, Savene, Totect, and Ethyol, to CNX Therapeutics, as part of its strategic shift in the pharmaceutical landscape. Find out more: eu1.hubs.ly/H04YbbQ0 #HealthcareNews #PharmaIndustry

Latest insights from our report reveals the staggering toll of obesity and overweight, which collectively led to a $9.3 billion reduction in Indiana's economy in 2022 – equivalent to 2% of the state's GDP. globaldata.com/health-economi… #obesity #healthcare #globaldata #EliLilly

Our latest study, supported by Eli Lilly, revealed the staggering toll that obesity and overweight had on New York’s economy – a $37.3 billion reduction in 2022, equivalent to 1.8% of the state's GDP. Learn more here: globaldata.com/health-economi… globaldata.com/media/healthca…

Our latest study, supported by Eli Lilly, revealed the staggering toll that obesity and overweight had on Iowa’s economy – a $5.7 billion reduction in 2022, equivalent to 2.5% of the state's GDP. 📖Read our detailed insights here: globaldata.com/health-economi… globaldata.com/media/healthca…

Our latest study, supported by Eli Lilly and Company , revealed the staggering toll that #obesity and #overweight had on #Texas' economy – a $39.8 billion reduction in 2022, equivalent to 1.7% of the state's GDP. Learn more here: globaldata.com/media/healthca… globaldata.com/health-economi…

📣GlobalData is at #CPhI in Barcelona! 🙌Congratulations to Snapdragon Chemistry, a Cambrex company, for your API win at the #CPhI Awards, presented onstage by GlobalData PharmSource’s Director Fiona Barry to Snapdragon’s Dr. Matthew Bio. We’re happy to meet people at #CPhI

Want to give your business an edge? Subscribe to #DECODED, our daily round-up of curated #news & insights specific to your industry 💡 Choose your sector now: eu1.hubs.ly/H068gG50

Stay ahead of the competition with a daily round-up of #healthcare industry #news delivered straight to your inbox 🚀 Stay informed, stay head. Subscribe now: eu1.hubs.ly/H068hRV0